- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: 2.5 mg ONGLYZA® (saxagliptin) tablet
Total 694 results
-
AstraZenecaCompleted
-
AstraZenecaParexelCompletedType 2 Diabetes MellitusUnited States
-
AstraZenecaCompletedType 2 Diabetes MellitusUnited States
-
Fulcrum TherapeuticsCompletedHealthy Adult SubjectsUnited States
-
GlaxoSmithKlineCompleted
-
Merck Sharp & Dohme LLCCompleted
-
University of Sao Paulo General HospitalInCor Heart InstituteCompletedPlatelet Aggregation During Acute Myocardial InfarctionBrazil
-
AstraZenecaCompletedHeart Failure | Type 2 Diabetes MellitusUnited States, Thailand, Korea, Republic of, Russian Federation, Ukraine, Hungary, Bulgaria, Chile, Canada, Romania
-
AstraZenecaCompletedType 2 Diabetes Mellitus, CKD and AlbuminuriaUnited States, Spain, Canada, Korea, Republic of, Mexico, Japan, Taiwan, Australia, South Africa
-
Cara Therapeutics, Inc.CompletedArthritis | Joint Diseases | Musculoskeletal Diseases | Rheumatic Diseases | Osteoarthritis, Knee | Osteoarthritis, HipUnited States
-
AstraZenecaCompletedBioequivalence, Log-transformed AUCss and Cmax,ss Values for Saxagliptin and MetforminUnited States
-
Chinese PLA General HospitalUnknown
-
BayerMerck Sharp & Dohme LLC; Duke Clinical Research Institute; Canadian VIGOUR CentreCompletedChronic Heart Failure With Preserved Ejection FractionSpain, United States, Belgium, Singapore, Taiwan, Canada, Japan, Italy, Austria, Bulgaria, Germany, Greece, Israel, Poland, Portugal, Hungary, Russian Federation, Argentina, Colombia, Malaysia, South Africa
-
KBP BiosciencesWorldwide Clinical TrialsCompletedHypertension | Chronic Kidney DiseasesUnited States
-
Cara Therapeutics, Inc.CompletedChronic Kidney Diseases | PruritusUnited States
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2Germany
-
GlaxoSmithKlineCompletedGastroparesisUnited States, Australia, Belgium, United Kingdom, Canada, Sweden
-
Mylan Pharmaceuticals IncCompleted
-
Cara Therapeutics, Inc.RecruitingPruritus | Notalgia ParestheticaUnited States, Poland, Spain, Canada, Germany
-
Darnitsa Pharmaceutical CompanyInternational Pharmaceutical Research CenterCompleted
-
AstraZenecaCompleted
-
AstraZenecaCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Kissei Pharmaceutical Co., Ltd.CompletedEndometriosisUnited States, Austria, Bulgaria, Czechia, France, Poland, Romania, Spain, Ukraine
-
Kissei Pharmaceutical Co., Ltd.TerminatedEndometriosisUnited States, Canada, Puerto Rico
-
Kissei Pharmaceutical Co., Ltd.CompletedEndometriosisUnited States, Austria, Bulgaria, Czechia, France, Poland, Romania, Spain, Ukraine, Hungary
-
Merck Sharp & Dohme LLCCompleted
-
ObsEva SATerminatedEndometriosisUnited States, Canada, Puerto Rico
-
TakedaWithdrawn
-
Axsome Therapeutics, Inc.CompletedObstructive Sleep Apnea | Narcolepsy | Postpartum | Excessive Sleepiness | Excessive Daytime SomnolenceUnited States
-
Merck Sharp & Dohme LLCPfizerCompleted
-
Overseas Pharmaceuticals, Ltd.Virginia Contract Research Organization Co., Ltd.Terminated
-
Merck Sharp & Dohme LLCCompleted
-
McNeil ABCompleted
-
University of VermontCompletedImpaired Glucose Tolerance | Pre-diabetes | Impaired Fasting GlucoseUnited States
-
Merck Sharp & Dohme LLCCompletedType 2 Diabetes Mellitus
-
Mylan Pharmaceuticals IncCompleted
-
Mylan Pharmaceuticals IncCompleted
-
Darnitsa Pharmaceutical CompanyInternational Pharmaceutical Research CenterCompleted
-
PfizerPfizerCompletedSickle Cell DiseaseUnited States
-
Future University in EgyptCompleted
-
Merck Sharp & Dohme LLCCompleted
-
H. Lundbeck A/SCompletedBioequivalence Study in Healthy SubjectsRussian Federation
-
University Hospital TuebingenTerminatedType 2 DiabetesGermany
-
Prof. Dr. Thomas ForstCompletedType2 Diabetes MellitusGermany
-
Sadat City UniversityBeni-Suef UniversityCompleted